Is The Value of FDG PET CT in Evaluating Renal Metastasis Underestimated A Case Report and Review of The Literature

Aras M., DEDE F., ÖNEŞ T., İnanır S., Erdil T. Y., Turoğlu H. T.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.22, ss.109-112, 2013 (Hakemli Dergi) identifier identifier

  • Yayın Türü: Makale / Vaka Takdimi
  • Cilt numarası: 22
  • Basım Tarihi: 2013
  • Doi Numarası: 10.4274/mirt.130
  • Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Derginin Tarandığı İndeksler: TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.109-112
  • Anahtar Kelimeler: Lung neoplasms, kidney neoplasms, Positron Emission Tomography, Fluorodeoxyglucose F18, computed tomography
  • Marmara Üniversitesi Adresli: Evet

Özet

Contrast-enhanced CT or MRI are used as a gold standard imaging modalities in the detection and characterization of renal masses. On the other hand, the role of FDG PET/CT in evaluating primary or metastatic cancers of the kidney is limited due to the excretion of FDG through urinary tract. We reported the FDG PET/CT of a lung cancer patient with multiple metastases in both kidneys which were missed in previous PET/CT, and underestimated on sequential diagnostic abdominal CT study.